Novartis: experimental heart drug fails key trial

Ionis' experimental drug, developed with Novartis, fails to meet its primary goal.

Published 3h1 sourceNotableupdated 3h

≈ 15sSpeed

The fact

The clinical trial focused on an innovative therapy for cardiovascular diseases.

Novartis assesses next steps for the treatment.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on September 5, 2026